Items where authors include "Din, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Gordon, M., Nigam, G.B., Sinopoulou, V. et al. (25 more authors) (2024) Update from 2010 (standard operating procedure): protocol for the 2024 British Society of Gastroenterology Guidelines on colorectal surveillance in inflammatory bowel disease. BMJ Open Gastroenterology, 11 (1). e001541. ISSN 2054-4774

Din, S., Segal, J., Blackwell, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). p1020-p1029. ISSN 2468-1156

Gros, B., Blackwell, J., Segal, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). pp. 1030-1040. ISSN 2468-1156

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Lindsay, J.O. orcid.org/0000-0003-3353-9590, Hind, D. orcid.org/0000-0002-6409-4793, Swaby, L. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11 (3). ISSN 2050-4365

Lindsay, J.O., Hind, D. orcid.org/0000-0002-6409-4793, Swaby, E. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Williams, K.M., Lamidi, S., Coe, P.O. et al. (96 more authors) (2023) Development of a core descriptor set for Crohn's anal fistula. Colorectal Disease, 25 (4). pp. 695-706. ISSN 1462-8910

Raine, T., Pavey, H., Qian, W. et al. (9 more authors) (2022) Establishment of a validated central reading system for ileocolonoscopy in an academic setting. Gut, 71. pp. 661-664. ISSN 0017-5749

Proceedings Paper

Lindsay, J., Din, S., Hawkey, C. et al. (11 more authors) (2021) OFR-9 An RCT of autologous stem-cell transplantation in treatment refractory Crohn’s disease (low-intensity therapy evaluation): ASTIClite. In: Gut. BSG Annual Meeting 2021, 08-12 Nov 2021, Virtual conference. BMJ Publishing Group Ltd and British Society of Gastroenterology , a4-a4.